Screener
MBX Biosciences, Inc. MBX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210593
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $6,974 | $2,977 |
| Accrued expenses | 7,415 | 12,346 |
| Operating lease liability, current | 178 | 172 |
| Total current liabilities | 14,567 | 15,495 |
| Share repurchase liability | 1 | 2 |
| Operating lease liability, net of current | 377 | 424 |
| Total liabilities | 14,945 | 15,921 |
Item 1. Financial Statements.
FAQ
- What is MBX Biosciences, Inc.'s operating lease liabilities (current)?
- MBX Biosciences, Inc. (MBX) reported operating lease liabilities (current) of $178K in Q1 2026.
- How has MBX Biosciences, Inc.'s operating lease liabilities (current) changed year-over-year?
- MBX Biosciences, Inc.'s operating lease liabilities (current) increased by 36.9% year-over-year, from $130K to $178K.
- What is the long-term trend for MBX Biosciences, Inc.'s operating lease liabilities (current)?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s operating lease liabilities (current) has grown at a 6.0% compound annual growth rate (CAGR), from $153K to $172K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about MBX Biosciences, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude